Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026)

Ascendis Pharma A has disclosed Exchange Rate Effect across 13 years of filings, most recently posting $3.6 million for Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at $3.6 million, up 139.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$413945.4 (up 94.8% YoY), and the FY2025 annual result was -$4.1 million, down 462.9% from the prior year.
• Exchange Rate Effect came in at $3.6 million for Q1 2026 at Ascendis Pharma A, up from -$570381.3 in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $4.4 million in Q1 2024 to a low of -$9.0 million in Q1 2025.
• The 5-year median for Exchange Rate Effect is -$570381.3 (2025), against an average of -$547131.9.
• Across the five-year window, Exchange Rate Effect soared 164.65% in 2024 and plunged 9903.63% in 2025, its largest moves.
• Ascendis Pharma A's Exchange Rate Effect stood at $2.3 million in 2022, then tumbled by 171.45% to -$1.6 million in 2023, then soared by 155.03% to $886934.2 in 2024, then tumbled by 164.31% to -$570381.3 in 2025, then surged by 727.67% to $3.6 million in 2026.
• The last three Exchange Rate Effect figures came in at $3.6 million (Q1 2026), -$570381.3 (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.